Peer-reviewedCC BY-NC-NDCirculation Journal
From Measurement to Management ― Lipoprotein(a) After Acute Coronary Syndrome ―
Related
- Temporal changes in lipoprotein(a) after acute coronary syndrome
- Lipoprotein(a) and early LDL-cholesterol target attainment after a first acute coronary syndrome: a real-world cohort study
- Lipoprotein(a), smoking, and diabetes are additive but not interactive risk factors for major adverse cardiovascular events after acute coronary syndrome
- Lipoprotein(a) After Myocardial Infarction: Residual Risk, Measurement, and the Unresolved Therapeutic Question
- Combined Triglyceride–High-density Lipoprotein Cholesterol Phenotypes and Cardiovascular Outcomes in Japanese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights from Clinical Deep Data Accumulation System-PCI
BibTeX
@article{minami2026from,
title = {{From Measurement to Management ― Lipoprotein(a) After Acute Coronary Syndrome ―}},
author = {Yoshiyasu Minami},
journal = {Circulation Journal},
year = {2026},
month = jul,
doi = {10.1253/circj.cj-26-0092},
url = {https://www.jstage.jst.go.jp/article/circj/90/8/90_CJ-26-0092/_article},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - From Measurement to Management ― Lipoprotein(a) After Acute Coronary Syndrome ―
AU - Yoshiyasu Minami
PY - 2026
DA - 2026/07/24
JO - Circulation Journal
DO - 10.1253/circj.cj-26-0092
UR - https://www.jstage.jst.go.jp/article/circj/90/8/90_CJ-26-0092/_article
SN - 1347-4820
SN - 1346-9843
ER -